164 related articles for article (PubMed ID: 34152566)
1. Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer.
Chen Y; Yuan J; Li Y; Li X; Yang Y; Li J; Li Y; Shen L
Hum Cell; 2021 Sep; 34(5):1446-1454. PubMed ID: 34152566
[TBL] [Abstract][Full Text] [Related]
2. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
[TBL] [Abstract][Full Text] [Related]
3. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model.
Jiang J; Wang DD; Yang M; Chen D; Pang L; Guo S; Cai J; Wery JP; Li L; Li HQ; Lin PP
Oncotarget; 2015 Jun; 6(17):15639-51. PubMed ID: 25909226
[TBL] [Abstract][Full Text] [Related]
5. Tracking circulating PD-L1-positive cells to monitor the outcome of patients with gastric cancer receiving anti-HER2 plus anti-PD-1 therapy.
Chong X; Li Y; Lu J; Feng X; Li Y; Zhang X
Hum Cell; 2024 Jan; 37(1):258-270. PubMed ID: 37889437
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer.
Li Y; Zhang X; Ge S; Gao J; Gong J; Lu M; Zhang Q; Cao Y; Wang DD; Lin PP; Shen L
Oncotarget; 2014 Aug; 5(16):6594-602. PubMed ID: 25026283
[TBL] [Abstract][Full Text] [Related]
7. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
Ge F; Zhang H; Wang DD; Li L; Lin PP
Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients.
Chen Y; Li Y; Qi C; Zhang C; Liu D; Deng Y; Fu Y; Khadka VS; Wang DD; Tan S; Liu S; Peng Z; Gong J; Lin PP; Zhang X; Li J; Li Y; Shen L
Cancer Lett; 2021 Oct; 517():78-87. PubMed ID: 34126192
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
[TBL] [Abstract][Full Text] [Related]
10. Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance.
Li Y; Zhang X; Liu D; Gong J; Wang DD; Li S; Peng Z; Li Y; Wang X; Lin PP; Li M; Shen L
Clin Cancer Res; 2018 Nov; 24(21):5261-5271. PubMed ID: 30012565
[No Abstract] [Full Text] [Related]
11. Prognostic value of circulating tumor cells and analysis of clinicopathological factors in liver cancer.
Cui K; Ou Y; Ning D; Li H; Xi Y; Li S
J Cancer Res Ther; 2022 Apr; 18(2):452-460. PubMed ID: 35645114
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
13. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
Zheng X; Fan L; Zhou P; Ma H; Huang S; Yu D; Zhao L; Yang S; Liu J; Huang A; Cai C; Dai X; Zhang T
Transl Oncol; 2017 Jun; 10(3):431-441. PubMed ID: 28448959
[TBL] [Abstract][Full Text] [Related]
14. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer.
Matsushita D; Uenosono Y; Arigami T; Yanagita S; Okubo K; Kijima T; Miyazono F; Hamanoue M; Hokita S; Nakashima S; Ohtsuka T; Natsugoe S
Cancer Chemother Pharmacol; 2021 Jun; 87(6):789-797. PubMed ID: 33641065
[TBL] [Abstract][Full Text] [Related]
16. Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer.
Li Y; Gong J; Zhang Q; Lu Z; Gao J; Li Y; Cao Y; Shen L
Br J Cancer; 2016 Jan; 114(2):138-45. PubMed ID: 26784122
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells as a window on metastasis biology in lung cancer.
Hou JM; Krebs M; Ward T; Sloane R; Priest L; Hughes A; Clack G; Ranson M; Blackhall F; Dive C
Am J Pathol; 2011 Mar; 178(3):989-96. PubMed ID: 21356352
[TBL] [Abstract][Full Text] [Related]
18. [A Rare Case of Extremely High Counts of EpCAM
Jiang TT; Li HP; Li YC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):711-715. PubMed ID: 35871746
[TBL] [Abstract][Full Text] [Related]
19. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.
Mascalchi M; Falchini M; Maddau C; Salvianti F; Nistri M; Bertelli E; Sali L; Zuccherelli S; Vella A; Matucci M; Voltolini L; Pegna AL; Luconi M; Pinzani P; Pazzagli M
J Cancer Res Clin Oncol; 2016 Jan; 142(1):195-200. PubMed ID: 26210156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
